Michigan Technological University   Report issue

Academic/Hospital Phase 4
Founded: Houghton MI United States (1885)

Organization Overview

First Clinical Trial
2019
NCT03768713
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Michigan Technological University

Active Ingredients

Drugs in Phase 4 Trials (1)

suvorexant (belsomra) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Sleep Initiation and Maintenance Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1